Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1989-07-07
1991-09-03
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
530387, 530388, 435 7021, 4351722, 935104, 935108, 935 95, C12N 520, C07K 1528, C12P 2108
Patent
active
050454668
ABSTRACT:
The invention is directed to hydridoma cell lines and the monoclonal antibodies produced by the cell lines, where the monoclonal antibodies specifically bind to the lipopolysaccharide endotoxin binding receptor of mammalian cells. Specifically, the monoclonal antibodies binds to a cell receptor which has a molecular mass of 80 kilodaltons, and is specific for the lipid A component of the lipopolysaccharide endotoxin. The monoclonal antibodies are specific for a carbohydrate component of the binding receptor in one instance, and for a protein/peptide receptor in another.
REFERENCES:
Roeder et al., Infection and Immunity 57(4):1054-58, 1989.
Jakway et al., Fed. Proc. 44: 1297, 1985.
Wright et al., J. Exp. Med. 164: 1876-88, 1986.
Kipps & Herzenberg, pp. 108.1-108.9 in "Handbook of Expt'l Immunology", vol. 4, Herzenberg et al, Eds. 1986, Blackwell Sci. Publ.
Wright et al. J. Immunology, 144(7): 2566-71, 1990.
Bright Stuart W.
Chen Taiying
Flebbe Linda M.
Lei Mei-Guey
Morrison David C.
Hutzell Paula
Kepplinger Esther L.
University of Kansas
LandOfFree
Purified mammalian cell binding receptor for bacterial lipopolys does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purified mammalian cell binding receptor for bacterial lipopolys, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified mammalian cell binding receptor for bacterial lipopolys will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1008879